Pharma News, 2018

The Massachusetts Institute of Technology (MIT) today announced they will invest US$1 billion into a new college for artificial intelligence.

Reuters) - European authorities are placing Zhejiang Huahai Pharmaceutical Co Ltd under higher supervision, the European Medicines Agency said on Monday, in the latest crackdown on the Chinese fir...

A commonly-used anti-psychotic drug could also be effective against triple negative breast cancer, the form of the disease that is most difficult to treat, new research has found.

People with a particular kind of irregular heartbeat called atrial fibrillation may experience a faster decline in thinking and memory skills and have a greater risk of dementia than those without atr...

CHICAGO, Oct.

TORONTO and CAMBRIDGE, MA, Oct.

From November 1 specialist clinicians in the UK will be able to prescribe cannabis-derived medicinal products for the first time after a change in the law, the Home Office has confirmed.

SOUTH SAN FRANCISCO, Calif.

As the timeline shortens for Albert Bourla to take over the reins of Pfizer from Chief Executive Officer Ian Read, the company has released details of the new senior management team that will co...

Although it is well established that autoreactive lymphocytes induce demyelination in multiple sclerosis, the exact antigenic targets that initiate disease are undefined.

TEL AVIV (Reuters) - Bristol-Myers Squibb Co and Israel’s Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid tumors.

(Reuters) - Johnson & Johnson said on Tuesday its blockbuster drug Stelara was found to be effective in treating a chronic bowel disease in a late-stage trial.